Correlation Between Biofil Chemicals and Neogen Chemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Neogen Chemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Neogen Chemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and Neogen Chemicals Limited, you can compare the effects of market volatilities on Biofil Chemicals and Neogen Chemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Neogen Chemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Neogen Chemicals.

Diversification Opportunities for Biofil Chemicals and Neogen Chemicals

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Biofil and Neogen is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and Neogen Chemicals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neogen Chemicals and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Neogen Chemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neogen Chemicals has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Neogen Chemicals go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Neogen Chemicals

Assuming the 90 days trading horizon Biofil Chemicals Pharmaceuticals is expected to under-perform the Neogen Chemicals. But the stock apears to be less risky and, when comparing its historical volatility, Biofil Chemicals Pharmaceuticals is 1.61 times less risky than Neogen Chemicals. The stock trades about -0.23 of its potential returns per unit of risk. The Neogen Chemicals Limited is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  216,870  in Neogen Chemicals Limited on September 1, 2024 and sell it today you would lose (7,250) from holding Neogen Chemicals Limited or give up 3.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Biofil Chemicals Pharmaceutica  vs.  Neogen Chemicals Limited

 Performance 
       Timeline  
Biofil Chemicals Pha 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical indicators, Biofil Chemicals is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Neogen Chemicals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neogen Chemicals Limited are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, Neogen Chemicals sustained solid returns over the last few months and may actually be approaching a breakup point.

Biofil Chemicals and Neogen Chemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biofil Chemicals and Neogen Chemicals

The main advantage of trading using opposite Biofil Chemicals and Neogen Chemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Neogen Chemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neogen Chemicals will offset losses from the drop in Neogen Chemicals' long position.
The idea behind Biofil Chemicals Pharmaceuticals and Neogen Chemicals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bonds Directory
Find actively traded corporate debentures issued by US companies
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope